Business Context and Reporting Period
This Form 8-K was filed by Anthem, Inc. (now Elevance Health, Inc.) on February 18, 2015. The report serves as a Regulation FD disclosure to communicate updated financial guidance to the market.
Key Financial Metrics
The filing does not provide historical revenue, profit, cash flow, margin, debt, or liquidity figures for the current or prior periods. The only financial data disclosed relates to forward-looking guidance for the full year 2015:
- Net Income Guidance: Greater than $9.30 per share.
- Adjusted Net Income Guidance: Greater than $9.70 per share (excluding amortization of other intangible assets).
- Amortization Impact: Greater than $0.40 per share.
- Investment Gains/Losses: The guidance assumes no investment gains or losses in 2015.
Material Changes
The filing does not report material changes to historical financial results compared to prior periods. The primary update is the reaffirmation of the previously issued full-year 2015 net income guidance.
Guidance, Outlook, and Risks
Management reaffirmed its outlook for 2015, explicitly stating that the guidance excludes any potential investment gains or losses. The filing notes that the information provided in Item 7.01 and the accompanying press release (Exhibit 99.1) is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and will not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the full text of the press release (Exhibit 99.1) for detailed assumptions behind the $9.30 and $9.70 per share guidance.
- Confirm the specific components of "other intangible assets" being amortized to understand the $0.40 per share adjustment.
- Monitor subsequent filings for any updates regarding investment portfolio performance, as the current guidance assumes zero impact from investment gains or losses.